These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27521468)

  • 21. Evaluation of the CDC proposed laboratory HIV testing algorithm among men who have sex with men (MSM) from five US metropolitan statistical areas using specimens collected in 2011.
    Masciotra S; Smith AJ; Youngpairoj AS; Sprinkle P; Miles I; Sionean C; Paz-Bailey G; Johnson JA; Owen SM
    J Clin Virol; 2013 Dec; 58 Suppl 1(Suppl 1):e8-e12. PubMed ID: 24342483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of increased HIV testing among MSM in The Netherlands.
    Reitsema M; Steffers L; Visser M; Heijne J; van Hoek AJ; Schim van der Loeff M; van Sighem A; van Benthem B; Wallinga J; Xiridou M; Mangen MJ
    AIDS; 2019 Oct; 33(12):1807-1817. PubMed ID: 30889012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting screening and social marketing to increase detection of acute HIV infection in men who have sex with men in Vancouver, British Columbia.
    Gilbert M; Cook D; Steinberg M; Kwag M; Robert W; Doupe G; Krajden M; Rekart M
    AIDS; 2013 Oct; 27(16):2649-54. PubMed ID: 23921608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High linkage to care in a community-based rapid HIV testing and counseling project among men who have sex with men in Copenhagen.
    Qvist T; Cowan SA; Graugaard C; Helleberg M
    Sex Transm Dis; 2014 Mar; 41(3):209-14. PubMed ID: 24521728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the cost-effectiveness of a pre-exposure prophylaxis program for HIV prevention for men who have sex with men in Japan.
    Yamamoto N; Koizumi Y; Tsuzuki S; Ejima K; Takano M; Iwami S; Mizushima D; Oka S
    Sci Rep; 2022 Feb; 12(1):3088. PubMed ID: 35197543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of environmental-structural communication interventions for HIV prevention in the female sex industry in the Dominican Republic.
    Sweat M; Kerrigan D; Moreno L; Rosario S; Gomez B; Jerez H; Weiss E; Barrington C
    J Health Commun; 2006; 11 Suppl 2():123-42. PubMed ID: 17148102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating the effectiveness and efficiency of US HIV prevention efforts using scenario and cost-effectiveness analysis.
    Holtgrave DR
    AIDS; 2002 Nov; 16(17):2347-9. PubMed ID: 12441812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How much should we pay for a new HIV diagnosis? A mathematical model of HIV screening in US clinical settings.
    Farnham PG; Sansom SL; Hutchinson AB
    Med Decis Making; 2012; 32(3):459-69. PubMed ID: 22247422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ten Years of Screening and Testing for Acute HIV Infection in North Carolina.
    Kuruc JD; Cope AB; Sampson LA; Gay CL; Ashby RM; Foust EM; Brinson M; Barnhart JE; Margolis D; Miller WC; Leone PA; Eron JJ
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):111-9. PubMed ID: 26761274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of nucleic acid testing relative to antigen/antibody combination immunoassay on the detection of acute HIV infection.
    De Souza MS; Phanuphak N; Pinyakorn S; Trichavaroj R; Pattanachaiwit S; Chomchey N; Fletcher JL; Kroon ED; Michael NL; Phanuphak P; Kim JH; Ananworanich J;
    AIDS; 2015 Apr; 29(7):793-800. PubMed ID: 25985402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness.
    Holtgrave DR
    J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cost-effectiveness of HIV self-testing strategy in men who have sex with men].
    Huang SZ; Dai WC; Li XF; Jiang XH; Tang WM; Zhou Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 May; 41(5):753-757. PubMed ID: 32447920
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania.
    Sweat M; Gregorich S; Sangiwa G; Furlonge C; Balmer D; Kamenga C; Grinstead O; Coates T
    Lancet; 2000 Jul; 356(9224):113-21. PubMed ID: 10963247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prioritization of prevention activities to combat the spread of HIV/AIDS in resource constrained settings: a cost-effectiveness analysis from Chad, Central Africa.
    Hutton G; Wyss K; N'Diékhor Y
    Int J Health Plann Manage; 2003; 18(2):117-36. PubMed ID: 12841152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV Infection Rates and Risk Behavior among Young Men undergoing community-based Testing in San Diego.
    Hoenigl M; Chaillon A; Morris SR; Little SJ
    Sci Rep; 2016 May; 6():25927. PubMed ID: 27181715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determining a cost effective intervention response to HIV/AIDS in Peru.
    Aldridge RW; Iglesias D; Cáceres CF; Miranda JJ
    BMC Public Health; 2009 Sep; 9():352. PubMed ID: 19765304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of HIV-prevention skills training for men who have sex with men.
    Pinkerton SD; Holtgrave DR; Valdiserri RO
    AIDS; 1997 Mar; 11(3):347-57. PubMed ID: 9147427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of the Mpowerment Project, a community-level intervention for young gay men.
    Kahn JG; Kegeles SM; Hays R; Beltzer N
    J Acquir Immune Defic Syndr; 2001 Aug; 27(5):482-91. PubMed ID: 11511826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing Cost-Effectiveness of HIV Testing Strategies: Targeted and Routine Testing in Washington, DC.
    Castel AD; Choi S; Dor A; Skillicorn J; Peterson J; Rocha N; Kharfen M
    PLoS One; 2015; 10(10):e0139605. PubMed ID: 26465771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.